Search

Becton Dickinson and Co

Ouvert

SecteurSoins de santé

183.61 1.86

Résumé

Variation du prix de l'action

24h

Actuel

Min

179.97

Max

182.1

Chiffres clés

By Trading Economics

Revenu

759M

449M

Ventes

269M

5B

P/E

Moyenne du Secteur

31.645

56.432

BPA

3.23

Rendement du dividende

2.36

Marge bénéficiaire

9.011

Employés

72,000

EBITDA

-23M

686M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+6.97% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

2.36%

2.27%

Prochains Résultats

5 nov. 2026

Date du Prochain Dividende

30 sept. 2026

Date du Prochain Détachement de Dividende

7 déc. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.2B

50B

Ouverture précédente

181.75

Clôture précédente

183.61

Sentiment de l'Actualité

By Acuity

52%

48%

247 / 339 Classement par Healthcare

Becton Dickinson and Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 sept. 2026, 19:52 UTC

Becton Dickinson and Co is trading modestly higher amid a broader market divergence from the recent trend of higher daily closes since Thursday.

17 sept. 2026, 20:07 UTC

Becton Dickinson and Co shares fell modestly on Thursday, closing below the 20-day moving average and near the lower end of their one-month range.

16 sept. 2026, 19:04 UTC

Becton Dickinson and Co shares fell sharply, reversing a trend of higher daily closes observed since Tuesday's close.

15 sept. 2026, 20:13 UTC

Becton Dickinson and Co shares are lower in after-market hours amid broader market caution following a decline in the manufacturing index and inflation concerns.

14 sept. 2026, 22:31 UTC

Becton Dickinson and Co is trading higher in after-market hours, continuing a trend from the past three sessions amid broader market dynamics and inflation concerns.

11 sept. 2026, 20:31 UTC

Becton Dickinson and Co shares are lower in after-market hours amid broader market weakness and speculation over potential Federal Reserve interest rate hikes.

10 sept. 2026, 20:01 UTC

Becton Dickinson shares are lower today, reflecting ongoing weakness amid a broader market backdrop following the European Central Bank's interest rate hike.

9 sept. 2026, 20:07 UTC

Becton Dickinson and Co's shares are higher today amid routine trading. No specific news has been identified to explain the movement.

8 sept. 2026, 23:41 UTC

Becton Dickinson and Co shares rose in after-market trading, recovering from earlier losses. The price remains below its 20-day moving average.

4 sept. 2026, 20:08 UTC

Becton Dickinson is lower today amid broader market declines following a strong jobs report that has pressured risk assets. No specific company news was identified.

2 sept. 2026, 20:08 UTC

Becton Dickinson shares are higher today, continuing a trend of slight gains since Tuesday's close, despite a minor pullback during the session.

1 sept. 2026, 23:56 UTC

Becton Dickinson and Co shares rose in after-market trading, reflecting a position above its 20-day moving average and near the top of its one-month range.

31 août 2026, 21:03 UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining a strong upward trajectory above the 20-day moving average. No specific news was identified.

28 août 2026, 20:08 UTC

Becton Dickinson shares are higher, reflecting gains since Thursday. The stock earlier reached a session high before pulling back slightly.

27 août 2026, 22:26 UTC

Becton Dickinson and Co shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

26 août 2026, 20:08 UTC

Becton Dickinson shares are higher today amid mixed market performance and recent inflation data, with no specific news identified to explain the movement.

25 août 2026, 23:36 UTC

Becton Dickinson shares are higher in after-market trading, positioned above its 20-day moving average and near the upper end of its one-month range.

24 août 2026, 19:46 UTC

Becton Dickinson is trading lower, influenced by rising oil prices and geopolitical tensions. The stock reached a session high earlier but has since declined.

21 août 2026, 23:01 UTC

Becton Dickinson shares are lower in after-market trading, following unusual activity despite a strong one-month gain and trading above the 20-day moving average.

20 août 2026, 20:06 UTC

Becton Dickinson and Co is trading higher, maintaining an upward trajectory since Wednesday's close, despite some intraday volatility. No specific news was identified.

19 août 2026, 21:01 UTC

Becton Dickinson and Co shares are lower in after-market trading, showing unusual weakness despite remaining above the 20-day moving average. No specific news was identified.

18 août 2026, 19:46 UTC

Becton Dickinson and Co shares are lower today, breaking a trend of higher daily closes amid rising Treasury yields and inflation concerns.

17 août 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

14 août 2026, 19:36 UTC

Becton Dickinson is trading higher today, despite a reported decline in retail sales for July that raised concerns about consumer demand.

13 août 2026, 22:01 UTC

Becton Dickinson shares are lower in after-market hours, continuing a decline from Thursday's close amid overall weakness in after-hours trading.

12 août 2026, 23:46 UTC

Event

Becton Dickinson announced successful enrollment completion in the PREVENT clinical trial for Phasix™ Mesh. Shares remain roughly flat in after-market trading.

11 août 2026, 22:26 UTC

Becton Dickinson is trading lower in after-market hours, reversing an initial gain. No specific news was identified to explain this price movement.

10 août 2026, 19:43 UTC

News

Becton Dickinson reports EPS of $3.23, exceeding estimates, and updates fiscal 2026 guidance, driving shares higher amid strong health care equipment sector gains.

7 août 2026, 21:11 UTC

News

Citigroup maintained its Buy rating on Becton Dickinson and raised its price target to $204, contributing to the stock's higher after-market trading.

6 août 2026, 23:01 UTC

Becton Dickinson and Co shares are higher in after-market hours, continuing a trend of three consecutive daily gains and remaining above the 20-day moving average.

Comparaison

Variation de prix

Becton Dickinson and Co prévision

Objectif de Prix

By TipRanks

6.97% hausse

Prévisions sur 12 Mois

Moyen 193.3 USD  6.97%

Haut 210 USD

Bas 175 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

10 ratings

5

Achat

5

Maintien

0

Vente

Sentiment

By Acuity

247 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.